These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10205762)

  • 21. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Choice of proton pump inhibitors].
    Starostin BD
    Voen Med Zh; 2001 Dec; 322(12):30-40, 96. PubMed ID: 11881475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Place and significance of proton pump inhibitors in current treatment of peptic ulcers].
    Maev IV
    Eksp Klin Gastroenterol; 2003; (3):12-13. PubMed ID: 14989296
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 27. [New paradigm of the GERB and long-term therapy with proton pump inhibitors].
    Isakova VA
    Eksp Klin Gastroenterol; 2006; (4):53-8. PubMed ID: 17269425
    [No Abstract]   [Full Text] [Related]  

  • 28. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
    MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
    [No Abstract]   [Full Text] [Related]  

  • 34. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 35. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.
    Devlin JW; Welage LS; Olsen KM
    Ann Pharmacother; 2005 Nov; 39(11):1844-51. PubMed ID: 16204393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of US databank. How safe are proton pump inhibitors?].
    MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136676
    [No Abstract]   [Full Text] [Related]  

  • 37. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current concepts in therapy of reflux disease].
    Kirchgatterer A; Aschl G; Hinterreiter M; Stadler B; Knoflach P
    Wien Med Wochenschr; 2001; 151(11-12):266-9. PubMed ID: 11515224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.
    Amidon PB; Jankovich R; Stoukides CA; Kaul AF
    Am J Manag Care; 2000 May; 6(5):593-601. PubMed ID: 10977467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.